Reports

Drug name	NICE TAs	Comments
Icosapent Ethyl	TA805 - Icosapent ethyl with statin therapy for reducing the risk of cardiovascular events in people with raised triglycerides	Specialist Initiation - use in line with NICE
Idarubicin injection		For hospital use only
Idarucizumab 2.5g/250ml solution for injection/infusion		When rapid reversal of Dabigatran anticoagulant effect is required
Idursulfase concentrate for infusion		NHSE commissioned.
Ifosfamide infusion		For hospital use only
Iloprost nebules		Hospital use only. NHS England commissioned.
Imatinib (Glivec®)	TA70 - Guidance on the use of imatinib for chronic myeloid leukaemia (partially updated by TA241 and TA251) TA86 - Imatinib for the treatment of unresectable and/or metastatic gastro-intestinal stromal tumours TA326 - Imatinib for the adjuvant treatment of gastrointestinal stromal tumours TA209 - Imatinib for the treatment of unresectable and/or metastatic gastrointestinal stromal tumours TA426 - Dasatinib, nilotinib and imatinib for untreated chronic myeloid leukaemia TA241 - Dasatinib, high-dose imatinib and nilotinib for the treatment of imatinib-resistant chronic myeloid leukaemia (CML) (part review of NICE technology appraisal guidance 70), and dasatinib and nilotinib for people with CML for whom treatment with imatinib has failed because of intolerance	Off-label use for melanoma with responsive c-KIT mutation
Imiglucerase injection		NHSE commissioned.
Imipenem with Cilastatin & Relebactam (Recarbrio®)		Microbiology and ID team recommendation only
Imipramine tablets		Specialist initiation only

First page
Previous page
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
Next page
Last page

University Hospitals Birmingham NHS Foundation Trust

Medicines Formulary

Reports